Immunopathogenesis of pediatric localized scleroderma

KS Torok, SC Li, HM Jacobe, SF Taber… - Frontiers in …, 2019 - frontiersin.org
Localized scleroderma (LS) is a complex disease characterized by a mixture of inflammation
and fibrosis of the skin that, especially in the pediatric population, also affects …

Autoantibodies in morphea: an update

S Khatri, KS Torok, E Mirizio, C Liu… - Frontiers in …, 2019 - frontiersin.org
Skin autoimmune conditions belong to a larger group of connective tissue diseases and
primarily affect the skin, but might also involve underlying tissues, such as fat tissue, muscle …

Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma

SC Li, GC Higgins, M Chen, KS Torok… - …, 2021 - academic.oup.com
Objective The aim of this study was to evaluate factors associated with extracutaneous
involvement (ECI) in juvenile localized scleroderma (jLS). Methods A prospective …

Preliminary evidence on abatacept safety and efficacy in refractory juvenile localized scleroderma

SC Li, KS Torok, SS Ishaq, M Buckley, B Edelheit… - …, 2021 - academic.oup.com
Objective To evaluate the safety and efficacy of abatacept treatment for refractory juvenile
localized scleroderma (jLS) in a retrospective study. Methods A multicentre cohort study was …

[HTML][HTML] Abatacept in the treatment of localized scleroderma: a pediatric case series and systematic literature review

I Kalampokis, YY Belina, AC Smidt - Seminars in Arthritis and Rheumatism, 2020 - Elsevier
Background Localized scleroderma (LS) is a rare chronic immune-mediated skin condition
of unknown etiology characterized by an inflammatory response in the skin and …

Juvenile localized scleroderma: updates and differences from adult-onset disease

N Vasquez-Canizares, SC Li - Rheumatic Disease Clinics, 2021 - rheumatic.theclinics.com
Localized scleroderma (LS), also known as morphea, is an idiopathic inflammatory and
sclerosing disorder affecting the skin and subcutaneous structures. 1, 2 Although skin …

Prospective evaluation of treatment response and disease reversibility of paediatric localized scleroderma (morphoea) to steroids and methotrexate using multi‐modal …

L Weibel, M Theiler, KJ Howell… - Journal of the …, 2020 - Wiley Online Library
Background Paediatric localized scleroderma is a severe inflammatory disorder associated
with tissue atrophy, often leading to disability. Assessing disease activity and response to …

Overview of Juvenile localized scleroderma and its management

SC Li, RJ Zheng - World Journal of Pediatrics, 2020 - Springer
Background Juvenile localized scleroderma (JLS) is a rare pediatric disease characterized
by inflammation and skin thickening. JLS is associated with deep tissue and extracutaneous …

Diagnosis and management of linear scleroderma in children

AG Peña-Romero… - Current Opinion in …, 2019 - journals.lww.com
Clinical evaluation, both physical exam and history, is the most important aspect in
diagnosing and assessing activity of linear scleroderma. Clinical scoring methods may be …

Morbidity and disability in juvenile localized scleroderma: the case for early recognition and systemic immunosuppressive treatment

SC Li, KM O'Neil, GC Higgins - The Journal of Pediatrics, 2021 - jpeds.com
Suzanne C. Li, MD, PhD1, Kathleen M. O'Neil, MD2, and Gloria C. Higgins, MD, PhD3
Juvenile localized scleroderma, also called morphea, is a chronic autoimmune and fibrosing …